CSE/CLC (CSE/CLC)

Canadian Securities Exchange: CSE/CLC · CAD

CA$0.03

+0.00 (0.0%)· Recorded snapshot

Market cap	6.2M
Revenue (ttm)	13.2M
Net income (ttm)	-4M
EPS (ttm)	-CA$0.02
Shares out	248.1M
Volume	29,500
Beta	-0.96

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 13.2M
Net income (ttm): -4M
EPS (ttm): -CA$0.02
Market cap: 6.2M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-37.8

P25 n/aP50 n/aP75 n/a

ROIC-4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CSE/CLC indicators

Market & fundamental data

Available fields

175

Groups with data

Currency

CAD

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-10-30
Enterprise value	CAD 12.4M
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2026-05-31
First seen	2026-05-10
Fiscal year end	February
Founded	2014
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA17104U1021
Last earnings date	2026-01-29
Last refreshed	2026-10-29
Market cap	CAD 6.2M
Next earnings date	2026-10-30
Price	CAD 0.03
Price currency	CAD
Sector	Healthcare
SIC code	5159
Stock price date	2026-10-29
Symbol	cse/CLC
Website	https://christinalakecannabis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-64.72%
EV/Sales	0.94x
FCF / EV yield	-8.22%
FCF yield	-16.47%
Industry forward P/E	34.38x
P/(OCF - SBC) ratio	558.82x
P/B ratio	0.67x
P/OCF ratio	63.42x
P/S ratio	0.47x
Price / tangible book value	0.67x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-9.15%
EBITDA margin	-8.97%
Gross margin	27.37%
Operating margin	-9.15%
Pretax margin	-30.45%
Profit margin	-30.45%
Profitable years	2
ROA	-3.67%
ROCE	-9.61%
ROE	-37.81%
ROIC	-4.04%
SBC / revenue	0.66%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
FCF growth (Q)	161.86%
Gross profit growth	-47.58%
Gross profit growth (Q)	-33.85%
Gross profit growth 3Y	22.05%
Gross profit growth 5Y	-5.32%
Net income growth years	2
OCF growth (Q)	9.08%
OCF growth 3Y	-52.48%
Operating income growth (Q)	-70.38%
Revenue growth	-18.09%
Revenue growth (Q)	-3.18%
Revenue growth (QoQ)	52.05%
Revenue growth 3Y	4.81%
Revenue growth 5Y	116.35%
Revenue growth years	4

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -1.1M
Depreciation and amortization	CAD 24,839
EBIT	CAD -1.2M
EBITDA	CAD -1.2M
EPS	CAD -0.02
FCF per share	CAD -0.00
Financing cash flow	CAD -1.3M
Free cash flow	CAD -1M
Free cash flow minus SBC	CAD -1.1M
Gross profit	CAD 3.6M
Investing cash flow	CAD -513,362
Net borrowing	CAD -1.3M
Net cash flow	CAD -1.7M
Net income	CAD -4M
Operating cash flow minus SBC	CAD 11,099
Operating income	CAD -1.2M
Revenue	CAD 13.2M
Stock-based compensation	CAD 86,692

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-0.59
Book value per share	CAD 0.04
Debt / equity	0.86
Interest coverage	-0.75
Long-term assets	CAD 10.4M
Long-term liabilities	CAD 3.4M
Net cash (debt)	CAD -6.2M
Net cash / market cap	-100.44%
Net debt / equity	0.67
Piotroski F-Score	3
Property, plant and equipment	CAD 9.7M
Shareholders' equity	CAD 9.3M
Tangible book value	CAD 9.3M
Tangible book value per share	CAD 0.04
Total assets	CAD 19.2M
Total cash	CAD 1.7M
Total debt	CAD 7.9M
Total liabilities	CAD 10M
WACC	8.63%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.64
Current assets	CAD 8.8M
Current liabilities	CAD 6.6M
Current ratio	1.33
Inventory turnover	1.67
Net working capital	CAD 5M
Quick ratio	0.44
Working capital	CAD 2.2M
Working capital turnover	3.31

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-40.67%
Shareholder yield	-40.67%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.03
1D price change	0%
1M price change	-16.67%
1M total return	-16.67%
1Y price change	-37.5%
1Y return CAGR	-37.52%
1Y total return	-37.5%
20-day SMA	CAD 0.03
200-day SMA	CAD 0.04
3Y price change	-44.44%
3Y return CAGR	-17.79%
3Y total return	-44.44%
50-day SMA	CAD 0.03
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.05
52-week high date	2025-12-30
52-week low	CAD 0.02
52-week low date	2026-09-15
5Y price change	-92.65%
5Y return CAGR	-40.67%
5Y total return	-92.65%
6M price change	-28.57%
6M total return	-28.57%
All-time high	CAD 1.10
All-time high date	2021-01-25
All-time low	CAD 0.02
All-time low date	2023-07-04
Average true range (ATR)	CAD 0.00
Average volume	51.5K
Beta (1Y)	-1
Beta (2Y)	-0.22
Beta (5Y)	-0.96
Change from 52-week high	-44.44%
Change from 52-week low	25%
Change from all-time high	-97.73%
Change from all-time low	66.67%
Change from open	0%
Day's gap	0%
Dollar volume	CAD 738
High price	CAD 0.03
Low price	CAD 0.03
Monthly RSI	39.89
Open price	CAD 0.03
Previous close	CAD 0.03
Price vs 150-day SMA	-23.78%
Price vs 20-day SMA	-6.72%
Price vs 200-day SMA	-30.56%
Price vs 50-day SMA	-4.94%
Relative volume	0.57
RSI	46.22
Sharpe ratio	0.4
Sharpe ratio (3Y)	0.8
Sortino ratio	0.66
Sortino ratio (3Y)	1.56
Volume	29.5K
Weekly RSI	43.17
YTD price change	-44.44%
YTD total return	-44.44%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	136.3M
Shares change (QoQ)	-14.3%
Shares change (YoY)	40.67%
Shares held by insiders	36%
Shares held by institutions	0.91%
Shares outstanding	248.1M

Deeper analysis on CSE/CLC

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/CLC report

Is a complete CSE/CLC research report available?

No complete published report is available for cse/CLC (CSE/CLC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/CLC (CSE/CLC)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/CLC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/CLC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/CLC

Frequently asked questions